Published online before print September 7, 2005, doi:10.1212/01.wnl.0000180362.90078.dc)
Received May 20, 2005
Accepted July 7, 2005
Sporadic late onset nemaline myopathy
Nizar Chahin MD, Duygu Selcen MD, and Andrew G. Engel MD*
From the Department of Neurology and Muscle Research Laboratory, Mayo Clinic, Rochester, MN.
* To whom correspondence should be addressed. E-mail: age{at}mayo.edu.
Abstract-- Objective: To review the clinicopathologic features and outcome of sporadic late onset nemaline myopathy (SLONM). Background: Non-HIV-related SLONM is an uncommon disease of undefined etiology. Methods: This study is based on clinical, EMG, histochemical, immunocytochemical, and electron microscopy evaluation, and long-term follow-up of 14 patients observed at the Mayo Clinic between 1975 and 2003. Results: The disease presented between 43 and 81 years and evolved subacutely. The weakness was predominantly proximal in 11, equal proximally and distally in 3, and asymmetric in 4; dysphagia was a symptom in 6. The EMG showed myopathic features with fibrillations but the serum CK level at the time of initial examination or reevaluation was normal or below the Mayo Clinics range of normal values for sex and age at the time of the assay. Seven patients had an associated monoclonal gammopathy. On light microscopy, the nemaline structures were best identified in 3-µm-thick frozen sections stained trichromatically or immunostained for -actinin or myotilin. Electron microscopy done in 12 cases identified the rods in all and revealed additional structural abnormalities. Seven patients with monoclonal gammopathy were followed for 1 to 5 years; five died of respiratory failure. Five patients without monoclonal gammopathy were followed for 4 to 23 years and none died of the disease. Immunotherapy in eight patients was of uncertain benefit. Conclusions: 1) Subacutely evolving weakness after age 40, normal to low CK level, myopathic EMG with fibrillations, and often a monoclonal gammopathy are clues for the diagnosis of sporadic late onset nemaline myopathy. 2) The diagnosis is confirmed by visualizing the rods in trichrome or immunostained cryosections. 3) An associated monoclonal gammopathy heralds an unfavorable prognosis.
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Dalakas and S. A. Smith
A "nema" of hope in the treatment of late-onset nemaline myopathy
Neurology,
August 12, 2008;
71(7):
472 - 473.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Benveniste, P. Laforet, O. Dubourg, S. Solly, L. Musset, S. Choquet, N. Azar, M. Fardeau, S. Herson, V. Leblond, et al.
STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHY
Neurology,
August 12, 2008;
71(7):
531 - 532.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Voermans, M. Minnema, M. Lammens, H. J. Schelhaas, A.v.d. Kooi, H. M. Lokhorst, and B. G. van Engelen
SPORADIC LATE-ONSET NEMALINE MYOPATHY EFFECTIVELY TREATED BY MELPHALAN AND STEM CELL TRANSPLANT
Neurology,
August 12, 2008;
71(7):
532 - 534.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Hutchinson and K Whyte
Neuromuscular disease and respiratory failure
Practical Neurology,
August 1, 2008;
8(4):
229 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brancaccio, N. Maffulli, and F. M. Limongelli
Creatine kinase monitoring in sport medicine
Br. Med. Bull.,
June 14, 2007;
(2007)
ldm014v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Pavlu, M P Carey, and J B Winer
Hypothyroidism and nemaline myopathy in an adult
J. Neurol. Neurosurg. Psychiatry,
May 1, 2006;
77(5):
708 - 709.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Keller, A. P. Hays, L. P. Rowland, B. Moghadaszadeh, A. H. Beggs, and G. Bhagat
Adult-Onset Nemaline Myopathy and Monoclonal Gammopathy
Arch Neurol,
January 1, 2006;
63(1):
132 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|